Elemental: The unique devastation of cancer in a pandemic
August 6, 2020
During a pandemic, cancer is all the more terrifying, uncertain, and lonely. UC Cancer Center researchers weigh in.
August 6, 2020
During a pandemic, cancer is all the more terrifying, uncertain, and lonely. UC Cancer Center researchers weigh in.
October 15, 2020
Researchers at the University of Cincinnati are investigating a new way to explore suspicious brain masses, potentially eliminating the need for unnecessary surgery and worry for patients.
November 17, 2020
A national study being led by UC researchers is investigating whether a medication already used to treat opioid use disorder in women who are pregnant may be more beneficial in an extended-release form.
August 15, 2022
Drs Melanie Cushion, Michael Farrell and Bruce Giffin have been named 2022 recipients of Daniel Drake Medals.
October 14, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, joined the Five to Thrive Live podcast to discuss "Humanizing Brain Tumors."
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
April 11, 2023
The University of Cincinnati's Atsuo Sasaki, PhD, is leading a multidisciplinary team that received National Institutes of Health funding to learn more about how an enzyme that was previously overlooked helps regulate lysosome and cellular function.
April 12, 2023
The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.
April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.